99 related articles for article (PubMed ID: 18820932)
1. Autoimmune lymphoproliferative syndrome-like syndrome presented as lupus-like syndrome with mycobacterial joint infection evolved into the lymphoma.
Hong YH; Lee CK
Rheumatol Int; 2009 Mar; 29(5):569-73. PubMed ID: 18820932
[TBL] [Abstract][Full Text] [Related]
2. The autoimmune lymphoproliferative syndrome (Canale-Smith) in adulthood.
Deutsch M; Tsopanou E; Dourakis SP
Clin Rheumatol; 2004 Feb; 23(1):43-4. PubMed ID: 14749982
[TBL] [Abstract][Full Text] [Related]
3. Rapid regression of lymphadenopathy upon rapamycin treatment in a child with autoimmune lymphoproliferative syndrome.
Janić MD; Brasanac CD; Janković JS; Dokmanović BL; Krstovski RN; Kraguljac Kurtović JN
Pediatr Blood Cancer; 2009 Dec; 53(6):1117-9. PubMed ID: 19588524
[TBL] [Abstract][Full Text] [Related]
4. Pyrimethamine treatment does not ameliorate lymphoproliferation or autoimmune disease in MRL/lpr-/- mice or in patients with autoimmune lymphoproliferative syndrome.
Rao VK; Dowdell KC; Dale JK; Dugan F; Pesnicak L; Bi LL; Hoffmann V; Penzak S; Avila NA; Fleisher TA; Puck JM; Straus SE
Am J Hematol; 2007 Dec; 82(12):1049-55. PubMed ID: 17674358
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate mofetil as an alternate immunosuppressor for autoimmune lymphoproliferative syndrome.
Kossiva L; Theodoridou M; Mostrou G; Vrachnou E; Le Deist F; Rieux-Laucat F; Kanariou MG
J Pediatr Hematol Oncol; 2006 Dec; 28(12):824-6. PubMed ID: 17164652
[TBL] [Abstract][Full Text] [Related]
6. Fluorodeoxyglucose positron emission tomography (FDG-PET) for monitoring lymphadenopathy in the autoimmune lymphoproliferative syndrome (ALPS).
Rao VK; Carrasquillo JA; Dale JK; Bacharach SL; Whatley M; Dugan F; Tretler J; Fleisher T; Puck JM; Wilson W; Jaffe ES; Avila N; Chen CC; Straus SE
Am J Hematol; 2006 Feb; 81(2):81-5. PubMed ID: 16432855
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of patients with lymphoproliferative neoplasms in the setting of systemic autoimmune diseases.
Suvajdzic N; Djurdjevic P; Todorovic M; Perunicic M; Stojanović R; Novkovic A; Mihaljevic B
Med Oncol; 2012 Sep; 29(3):2207-11. PubMed ID: 21755372
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous manifestations as presenting sign of autoimmune lymphoproliferative syndrome in childhood.
Auricchio L; Vitiello L; Adriani M; Ferri P; Chiocchetti A; Pettinato G; Racioppi L; Maiuri L; Dianzani U; Pignata C
Dermatology; 2005; 210(4):336-40. PubMed ID: 15942224
[TBL] [Abstract][Full Text] [Related]
9. Other Iatrogenic Immunodeficiency-associated Lymphoproliferative Disorder Presenting as Primary Bone Lymphoma in a Patient with Rheumatoid Arthritis.
Ishiguro K; Hayashi T; Aoki Y; Murakami R; Ikeda H; Ishida T
Intern Med; 2016; 55(16):2259-64. PubMed ID: 27523005
[TBL] [Abstract][Full Text] [Related]
10. Spotlight on autoimmune lymphoproliferative syndrome.
Ferrer E; Moral MA; Bozzo J
Drug News Perspect; 2007 May; 20(4):260-2. PubMed ID: 17637938
[TBL] [Abstract][Full Text] [Related]
11. Hemophagocytosis in Cutaneous Autoimmune Disease.
Kerl K; Wolf IH; Cerroni L; Wolf P; French LE; Kerl H
Am J Dermatopathol; 2015 Jul; 37(7):539-43. PubMed ID: 25062264
[TBL] [Abstract][Full Text] [Related]
12. Use of Sirolimus (Rapamycin) for Treatment of Cytopenias and Lymphoproliferation Linked to Autoimmune Lymphoproliferative Syndrome (ALPS). Two Case Reports.
Cayrol J; Garrido Colino C
J Pediatr Hematol Oncol; 2017 May; 39(4):e187-e190. PubMed ID: 28234735
[TBL] [Abstract][Full Text] [Related]
13. Use of mycophenolate mofetil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndrome.
Rao VK; Dugan F; Dale JK; Davis J; Tretler J; Hurley JK; Fleisher T; Puck J; Straus SE
Br J Haematol; 2005 May; 129(4):534-8. PubMed ID: 15877736
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune lymphoproliferative syndrome (ALPS): a case with congenital onset.
Kahwash SB; Fung B; Savelli S; Bleesing JJ; Qualman SJ
Pediatr Dev Pathol; 2007; 10(4):315-9. PubMed ID: 17638424
[TBL] [Abstract][Full Text] [Related]
15. [Primary central nervous system lymphoma in a patient with systemic lupus erythematosus].
Pisoni CN; Grinberg AR; Plana JL; Freue RD; Manni JA; Paz L
Medicina (B Aires); 2003; 63(3):221-3. PubMed ID: 12876906
[TBL] [Abstract][Full Text] [Related]
16. Kikuchi's disease associated with systemic lupus erythematosus and autoimmune-like hepatitis.
Tănăsescu C; Niţescu D; Stăniceanu F; Ardeleanu C; Atanasiu C
Rom J Intern Med; 2003; 41(3):299-305. PubMed ID: 15526514
[TBL] [Abstract][Full Text] [Related]
17. Pathological findings in human autoimmune lymphoproliferative syndrome.
Lim MS; Straus SE; Dale JK; Fleisher TA; Stetler-Stevenson M; Strober W; Sneller MC; Puck JM; Lenardo MJ; Elenitoba-Johnson KS; Lin AY; Raffeld M; Jaffe ES
Am J Pathol; 1998 Nov; 153(5):1541-50. PubMed ID: 9811346
[TBL] [Abstract][Full Text] [Related]
18. Response to steroid therapy in autism secondary to autoimmune lymphoproliferative syndrome.
Shenoy S; Arnold S; Chatila T
J Pediatr; 2000 May; 136(5):682-7. PubMed ID: 10802504
[TBL] [Abstract][Full Text] [Related]
19. Bilateral uveitis in a patient with autoimmune lymphoproliferative syndrome.
Lim WK; Ursea R; Rao K; Buggage RR; Suhler EB; Dugan F; Chan CC; Straus SE; Nussenblatt RB
Am J Ophthalmol; 2005 Mar; 139(3):562-3. PubMed ID: 15767081
[TBL] [Abstract][Full Text] [Related]
20. Inherited and acquired death receptor defects in human Autoimmune Lymphoproliferative Syndrome.
Rieux-Laucat F
Curr Dir Autoimmun; 2006; 9():18-36. PubMed ID: 16394653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
